Alaska Air Group, Inc.

Fundamentals3.0
Price Action4.0
News Sentiment6.0
AI Rating
4.0

Key Drivers

  • Margin Compression
  • Heavy Leverage
  • Liquidity Strain

AI
AI Summary

4.0

ALK is a margin-and-balance-sheet recovery trade—not a simple post-merger growth story—so investors should wait for Hawaiian synergies and international expansion to produce sustained EBITDA and free-cash-flow improvement, as high leverage leaves little cushion against fuel-cost spikes or integration missteps.

SynergyPotential
LeverageRisk
MarginRecovery‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

3.0

Key Financial Insights:

  • •Margin Compression
  • •Heavy Leverage
  • •Liquidity Strain

ALK faces elevated financial risk as weakening profitability, negative working capital, and rising leverage outweigh its operating cash flow and low sales/book valuation.

LeverageRisk
ValueTrap

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • •Volatile sideways trend
  • •Support holding
  • •Weak momentum

ALK is mildly bearish last month, holding support at $39.68–$40.18 but needing to reclaim $41.16–$41.33 to improve momentum.

ALK
TechnicalAnalysis
Support Level: $39.68–$40.18
Resistance Level: $41.16–$41.33

Volatile decline after the

Sentiment & News

6.0

Key News Insights:

  • •Record Alkane Profit
  • •Alaska Air Weakness
  • •Agomab Trial Progress

ALK-related news is mixed: Alkane's record earnings and exploration success are strongly positive, while Alaska Air faces share-price pressure despite expansion plans and Agomab advances its IPF drug program.

AlkaneGrowth

The overall signal is issuer-specific, with Alkane showing the clearest near-term positive catalyst